Arch Venture Management, LLC Erasca, Inc. Transaction History
Arch Venture Management, LLC
- $171 Million
- Q2 2024
A detailed history of Arch Venture Management, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Arch Venture Management, LLC holds 11,055,554 shares of ERAS stock, worth $29.8 Million. This represents 15.29% of its overall portfolio holdings.
Number of Shares
11,055,554
Previous 11,055,554
-0.0%
Holding current value
$29.8 Million
Previous $22.8 Million
14.56%
% of portfolio
15.29%
Previous 33.14%
Shares
1 transactions
Others Institutions Holding ERAS
# of Institutions
133Shares Held
205MCall Options Held
3.1KPut Options Held
142K-
Frazier Life Sciences Management, L.P. Menlo Park, CA16.2MShares$43.8 Million2.26% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$43.8 Million4.2% of portfolio
-
Suvretta Capital Management, LLC New York, NY13.8MShares$37.2 Million1.36% of portfolio
-
Black Rock Inc. New York, NY10.6MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$27.9 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $330M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...